CDC Says YES To Administer Covid Vaccine Booster Shots


CDC Says YES OK to administer Covid vaccine booster shots to vulnerable Americans!

It’s official, the Centers for Disease Control and Prevention gave final approval Friday to start administering Covid-19 booster shots to Pfizer and Moderna vaccine recipients. Get all the details on the Covid Vaccine Booster shots… reports that the approval comes hours after a key panel unanimously voted to endorse third doses for immunocompromised Americans.

CDC Director Dr. Rochelle Walensky said in a statement:

At a time when the Delta variant is surging, an additional vaccine dose for some people with weakened immune systems could help prevent serious and possibly life-threatening COVID-19 cases within this population.

The CDC’s decision and recommendation by the Advisory Committee on Immunization Practices followed the Food and Drug Administration’s approval late Thursday of the booster shots for immunocompromised patients. With both agencies’ OK, booster doses could start being administered immediately.

Dr. Camille Nelson Kotton, a transplant and infectious disease specialist at Massachusetts General Hospital, told the panel in strongly supporting boosters for patients with weak immune systems.

She said:

Over the past almost year and a half I have taken care of many patients with a life-threatening disease, and including deadly disease, and even after a vaccination who are immunocompromised. They’re just suffering from a lack of good vaccine protection, we know that vaccine efficacy is diminished in this population.

According to NBCNews:

The FDA’s approval cleared third doses of Pfizer and Moderna vaccines for “solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.”

Walensky said:

Emerging data suggest some people with moderately to severely compromised immune systems do not always build the same level of immunity compared to people who are not immunocompromised. While people who are immunocompromised make up about 3% of the U.S. adult population, they are especially vulnerable to COVID-19 because they are more at risk of serious, prolonged illness.

The agencies didn’t clear boosters for other fully vaccinated individuals or for recipients of Johnson & Johnson’s vaccine manufactured under its Janssen vaccine division.

CDC’s Dr. Neela Goswami wrote in her presentation to ACIP:

Currently, there are not data to support the use of an additional mRNA COVID-19 vaccine dose after a primary Janssen Covid-19 vaccine in immunocompromised people. FDA and CDC are actively working to provide guidance on this issue.